Skip to main content

Jerome Jeffrey Federspiel

Assistant Professor of Obstetrics and Gynecology
Obstetrics and Gynecology, Maternal Fetal Medicine
Box 3967 Med Ctr, Durham, NC 27710
2608 Erwin Road, Suite 200, Durham, NC 27705

Overview


Dr. Federspiel is a maternal fetal medicine physician at Duke University. His clinical and research interests focus on the care of people with cardiovascular and hematologic complications of pregnancy.

Current Appointments & Affiliations


Assistant Professor of Obstetrics and Gynecology · 2022 - Present Obstetrics and Gynecology, Maternal Fetal Medicine, Obstetrics and Gynecology
Assistant Professor in Population Health Sciences · 2023 - Present Population Health Sciences, Basic Science Departments
Assistant Professor in Medicine · 2024 - Present Medicine, Hematology, Medicine

In the News


Published August 23, 2023
A Multifaceted Effort to Reduce Maternal Mortality
Published August 1, 2023
Q & A with Specialist: Getting Pregnant With a Heart Condition

View All News

Recent Publications


Moving the ACR's Reproductive Health Guidelines Into Practice

Journal Article JCR: Journal of Clinical Rheumatology · April 23, 2025 BackgroundProject ECHO (Extension for Community Healthcare Outcomes) links experts with community providers through video teleconferences that include both didactics and case discussions. ... Full text Cite

The Utility of a Critical Antibody Titer in Anti-K Alloimmunized Pregnancies: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy.

Journal Article Transfus Med Rev · April 10, 2025 Anti-Kell (anti-K) alloimmunization is a known cause of severe hemolytic disease of the fetus and newborn (HDFN), yet the utility of a critical maternal antibody titer in guiding clinical management remains debated. We conducted a systematic review and met ... Full text Link to item Cite

Hereditary Hemorrhagic Telangiectasia: Pregnancy and Delivery-Specific Considerations and Outcomes.

Conference Am J Perinatol · April 2025 Prior studies have evaluated maternal outcomes in patients with hereditary hemorrhagic telangiectasia (HHT), yet pregnancy- and delivery-specific data remain limited. This study aims to evaluate pregnancy and delivery outcomes in patients with HHT.This ret ... Full text Link to item Cite
View All Publications

Recent Grants


Advancing Reproductive Rheumatology through Research Mentoring

ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2029

PREP and GO Study: PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

ResearchPrincipal Investigator · Awarded by International Network of VENous Thromboembolism Clinical Research Networks · 2024 - 2027

PREP and GO Study: PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

ResearchPrincipal Investigator · Awarded by University of Calgary · 2024 - 2026

View All Grants

Education, Training & Certifications


University of North Carolina, Chapel Hill, School of Medicine · 2015 M.D.
University of North Carolina, Chapel Hill · 2013 Ph.D.